Professional societies recommend continuing ACE inhibitors and ARBs in patients with COVID-19. Trials testing whether they might actually be of benefit have ramped up and begun recruiting.
from WebMD Health https://ift.tt/2VbgGHp
Tuesday, 7 April 2020
Stay on Angiotensin Drugs' Still the Message as Trials Begin
from WebMD Health https://ift.tt/2VbgGHp
0 comments:
Post a Comment